Vanberra Signal

NovioSense

Curated by Signal

In the eye connected continuous glucose monitor for diabetes

Overview

NovioSense has developed a small and flexible spring like device to be inserted under lower eye-lid. Device can detect minute changes in the sugar levels and calibrate the same to body glucose levels. Device is wirelessly connected to microchips which can read the data. it can be used for both continuous and on-demand monitoring in diabetics. The company owns a issued EU patent and also expects market in 2018.

Key facts

Founded
2012

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Platform offering solutions for healthcare practices

    Health TechnologyApeldoorn, Netherlands
  • Provider of software for patient education

    Health TechnologyNetherlands
  • Digital wound monitoring tool for healthcare professionals

    Health TechnologySittard, Netherlands

About NovioSense

What does NovioSense do?

NovioSense has developed a small and flexible spring like device to be inserted under lower eye-lid.

Where is NovioSense headquartered?

NovioSense is headquartered in Nijmegen, Netherlands.

When was NovioSense founded?

NovioSense was founded in 2012.

Which sector is NovioSense in?

NovioSense operates in Health Technology.

Who are NovioSense's competitors?

Companies similar to NovioSense include PraQties, Life Circle, and Woundmonitor.